Home › Stock analysis › RCEL
AVITA Medical (RCEL) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
What changed since yesterday
- Closed at $13.04, -2.76% vs the prior close of $13.41.
- Volume 318.35K shares, 0.6x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
RCEL dips 2.8% to $13.04. Closed at $13.04, -2.76% vs the prior close of $13.41. Day range $12.95–$13.47, opened at $13.25.
Last close$13.04-2.76%
Day range12.95–13.47
Open13.25
Volume318.35K
52-week range3.22–13.73
Avg volume (20d)344.04K
RCEL daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — RCEL dips 2.8% to $13.04
- Closed at $13.04, -2.76% vs the prior close of $13.41. Day range $12.95–$13.47, opened at $13.25.
- Volume was 318.35K shares, 0.6x its 50-day average of 516.32K.
- Price is +20.1% vs its 50-day average ($10.86) and +118.9% vs its 200-day average ($5.96).
- 52-week range $3.22–$13.73; today's close sits at 93% of that range, 5.0% below the 52-week high.
Oct 15, 2026 — RCEL rises 2.4% to $13.41, a 52-week high
- Closed at $13.41, +2.37% vs the prior close of $13.10. Day range $12.89–$13.58, opened at $13.02.
- Volume was 388.50K shares, 0.8x its 50-day average of 511.95K.
- Price is +25.4% vs its 50-day average ($10.69) and +127.0% vs its 200-day average ($5.91).
- 52-week range $3.22–$13.73; today's close sits at 97% of that range, 2.3% below the 52-week high.
Oct 14, 2026 — RCEL dips 1.9% to $13.10
- Closed at $13.10, -1.95% vs the prior close of $13.36. Day range $12.80–$13.28, opened at $13.16.
- Volume was 524.50K shares, 1.0x its 50-day average of 503.90K.
- Price is +24.6% vs its 50-day average ($10.51) and +123.6% vs its 200-day average ($5.86).
- 52-week range $3.22–$13.73; today's close sits at 94% of that range, 4.6% below the 52-week high.
Oct 13, 2026 — RCEL ends flat (-0.1%) to $13.36
- Closed at $13.36, -0.07% vs the prior close of $13.37. Day range $13.15–$13.70, opened at $13.41.
- Volume was 294.50K shares, 0.6x its 50-day average of 499.96K — lighter than usual.
- Price is +29.2% vs its 50-day average ($10.34) and +130.0% vs its 200-day average ($5.81).
- 52-week range $3.22–$13.73; today's close sits at 96% of that range, 2.7% below the 52-week high.
Oct 12, 2026 — RCEL rises 1.2% to $13.37, a 52-week high
- Closed at $13.37, +1.21% vs the prior close of $13.21. Day range $12.91–$13.73, opened at $13.32.
- Volume was 319.30K shares, 0.6x its 50-day average of 495.99K.
- Price is +31.5% vs its 50-day average ($10.17) and +132.1% vs its 200-day average ($5.76).
- 52-week range $3.22–$13.73; today's close sits at 97% of that range, 2.6% below the 52-week high.
Oct 9, 2026 — RCEL dips 0.9% to $13.21
- Closed at $13.21, -0.90% vs the prior close of $13.33. Day range $13.00–$13.71, opened at $13.49.
- Volume was 280.50K shares, 0.6x its 50-day average of 492.29K — lighter than usual.
- Price is +32.3% vs its 50-day average ($9.99) and +131.3% vs its 200-day average ($5.71).
- 52-week range $3.22–$13.71; today's close sits at 95% of that range, 3.6% below the 52-week high.
Oct 8, 2026 — RCEL rises 2.1% to $13.33, a 52-week high
- Closed at $13.33, +2.15% vs the prior close of $13.05. Day range $12.53–$13.40, opened at $12.87.
- Volume was 347.20K shares, 0.7x its 50-day average of 487.20K.
- Price is +35.8% vs its 50-day average ($9.81) and +135.4% vs its 200-day average ($5.66).
- 52-week range $3.22–$13.50; today's close sits at 98% of that range, 1.3% below the 52-week high.
Oct 7, 2026 — RCEL rises 0.5% to $13.05
- Closed at $13.05, +0.46% vs the prior close of $12.99. Day range $12.59–$13.31, opened at $12.82.
- Volume was 262.50K shares, 0.5x its 50-day average of 483.97K — lighter than usual.
- Price is +35.4% vs its 50-day average ($9.64) and +132.5% vs its 200-day average ($5.61).
- 52-week range $3.22–$13.50; today's close sits at 96% of that range, 3.3% below the 52-week high.
Oct 6, 2026 — RCEL dips 2.0% to $12.99
- Closed at $12.99, -1.96% vs the prior close of $13.25. Day range $12.39–$13.50, opened at $13.38.
- Volume was 408.70K shares, 0.9x its 50-day average of 478.36K.
- Price is +37.2% vs its 50-day average ($9.47) and +133.5% vs its 200-day average ($5.56).
- 52-week range $3.22–$13.50; today's close sits at 95% of that range, 3.8% below the 52-week high.
Oct 5, 2026 — RCEL jumps 4.2% to $13.25, a 52-week high, 3 up days in a row
- Closed at $13.25, +4.17% vs the prior close of $12.72. Day range $12.53–$13.48, opened at $12.64.
- Volume was 418.50K shares, 0.9x its 50-day average of 471.63K.
- Price is +42.4% vs its 50-day average ($9.30) and +140.2% vs its 200-day average ($5.52).
- 52-week range $3.22–$13.48; today's close sits at 98% of that range, 1.7% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — RCEL jumps 5.9% to $12.72, a 52-week high
- Closed at $12.72, +5.91% vs the prior close of $12.01. Day range $12.02–$12.76, opened at $12.07.
- Volume was 391.20K shares, 0.8x its 50-day average of 467.53K.
- Price is +39.3% vs its 50-day average ($9.13) and +132.7% vs its 200-day average ($5.47).
- 52-week range $3.22–$12.76; today's close sits at 100% of that range, 0.3% below the 52-week high.
RCEL latest news & SEC filings
Every SEC filing by or about RCEL in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 25, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 24, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- O'Toole David D bought 2,000 shares at $3.97 (≈$7.94K) on Jun 12, 2026
- O'Toole David D bought 2,000 shares at $3.97 (≈$7.94K) on Jun 12, 2026
- O'Toole David D bought 2,000 shares at $3.97 (≈$7.94K) on Jun 12, 2026
- O'Toole David D bought 2,000 shares at $3.97 (≈$7.94K) on Jun 12, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Aug 6, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Item 5.07 — Reported shareholder vote results.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $21.70M (prior year $18.42M) (+17.8% vs Jun 30, 2025)
- Net income: -$7.66M (prior year -$9.92M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.25 (prior year -$0.38) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade RCEL
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Feb 12, 2026, Jan 13, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.62% (largest 6.0%).
- Liquidity: about 344.04K shares (≈$4.49M) trade per day on average.
- 52-week position: $13.04 vs a range of $3.22–$13.73 (93% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: David D O'Toole bought 2,000 shares on Jun 12, 2026.
- Latest filings: 8-K Aug 11, 2026; 10-Q Aug 6, 2026; 8-K Aug 6, 2026.
- Share count: 30.93M shares outstanding (Aug 3, 2026), +16.2% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
RCEL market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 13.25 | 13.47 | 12.95 | 13.04 | 318.35K |
| Oct 15, 2026 | 13.02 | 13.58 | 12.89 | 13.41 | 388.50K |
| Oct 14, 2026 | 13.16 | 13.28 | 12.80 | 13.10 | 524.50K |
| Oct 13, 2026 | 13.41 | 13.70 | 13.15 | 13.36 | 294.50K |
| Oct 12, 2026 | 13.32 | 13.73 | 12.91 | 13.37 | 319.30K |
| Oct 9, 2026 | 13.49 | 13.71 | 13.00 | 13.21 | 280.50K |
| Oct 8, 2026 | 12.87 | 13.40 | 12.53 | 13.33 | 347.20K |
| Oct 7, 2026 | 12.82 | 13.31 | 12.59 | 13.05 | 262.50K |
| Oct 6, 2026 | 13.38 | 13.50 | 12.39 | 12.99 | 408.70K |
| Oct 5, 2026 | 12.64 | 13.48 | 12.53 | 13.25 | 418.50K |
| Oct 2, 2026 | 12.07 | 12.76 | 12.02 | 12.72 | 391.20K |
| Oct 1, 2026 | 11.77 | 12.40 | 11.73 | 12.01 | 496.50K |
| Sep 30, 2026 | 11.90 | 12.12 | 11.60 | 11.73 | 249.70K |
| Sep 29, 2026 | 11.73 | 12.11 | 11.63 | 11.96 | 253.50K |
| Sep 28, 2026 | 11.63 | 11.76 | 11.34 | 11.67 | 208.10K |
| Sep 25, 2026 | 11.64 | 12.23 | 11.56 | 11.84 | 341.40K |
| Sep 24, 2026 | 10.95 | 11.76 | 10.91 | 11.58 | 420.50K |
| Sep 23, 2026 | 11.49 | 11.68 | 10.87 | 10.95 | 237.30K |
| Sep 22, 2026 | 10.86 | 11.81 | 10.71 | 11.49 | 525.40K |
| Sep 21, 2026 | 11.04 | 11.04 | 10.61 | 10.84 | 194.70K |
About AVITA Medical
AVITA Medical (RCEL) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in VALENCIA, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1762303.
RCEL board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jeremy Curnock Cook | Director | Jun 4, 2026 |
| Suzanne Crowe | Director | Jun 4, 2026 |
| Robert Mcnamara | Director | Jun 4, 2026 |
| Jan Stern Reed | Director | Jun 4, 2026 |
| Michael E Tarnoff | Director | Jun 4, 2026 |
| Cary Guy Vance | President and CEO | Jun 1, 2026 |
| Joseph Fralin Woody | Director | Jun 10, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Nicole Kelsey | Chief Legal Officer | Feb 19, 2026 |
| David D O'Toole | CFO | Aug 24, 2026 |
| Cary Guy Vance | President and CEO | Jun 1, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 12, 2026 | David D O'Toole | Buy | 2,000 | $3.97 |
| Jun 12, 2026 | David D O'Toole | Buy | 2,000 | $3.97 |
| Jun 12, 2026 | David D O'Toole | Buy | 2,000 | $3.97 |
| Jun 12, 2026 | David D O'Toole | Buy | 2,000 | $3.97 |
| Jun 9, 2026 | Joseph Fralin Woody | Buy | 5,200 | $4.00 |
| Jun 9, 2026 | Joseph Fralin Woody | Buy | 5,200 | $4.00 |
| Jun 9, 2026 | Joseph Fralin Woody | Buy | 5,200 | $4.00 |
| Jun 9, 2026 | Joseph Fralin Woody | Buy | 5,200 | $4.00 |
| Jun 9, 2026 | Joseph Fralin Woody | Buy | 5,000 | $4.18 |
| Jun 9, 2026 | Joseph Fralin Woody | Buy | 5,000 | $4.20 |
| Jun 9, 2026 | Joseph Fralin Woody | Buy | 5,000 | $4.18 |
| Jun 9, 2026 | Joseph Fralin Woody | Buy | 5,000 | $4.20 |
| Jun 9, 2026 | Joseph Fralin Woody | Buy | 5,000 | $4.18 |
| Jun 9, 2026 | Joseph Fralin Woody | Buy | 5,000 | $4.20 |
| Jun 9, 2026 | Joseph Fralin Woody | Buy | 5,000 | $4.18 |
RCEL financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $71.61M | $-48.59M | -1.74 | $-31.20M |
| Dec 31, 2024 | $64.25M | $-61.84M | -2.39 | $-48.94M |
| Dec 31, 2023 | $50.14M | $-35.38M | -1.40 | $-38.01M |
| Dec 31, 2022 | $34.42M | $-26.66M | 1.07 | $-19.09M |
| Jun 30, 2021 | $29.23M | $-26.58M | 1.17 | $-25.90M |
Latest balance sheet: total assets $47.78M, total liabilities $75.61M, cash $9.14M (as of Jun 30, 2026).
RCEL earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $4.75 |
| May 14, 2026 | 8-K Item 2.02 (results) | $4.36 |
| Feb 12, 2026 | 8-K Item 2.02 (results) | $3.72 |
| Jan 13, 2026 | 8-K Item 2.02 (results) | $3.30 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $3.40 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $5.38 |
| May 8, 2025 | 8-K Item 2.02 (results) | $9.33 |
| Feb 13, 2025 | 8-K Item 2.02 (results) | $8.78 |
| Jan 7, 2025 | 8-K Item 2.02 (results) | $14.06 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $12.40 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 13, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on RCEL
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.